Stacey L. Porter - Oct 15, 2021 Form 3 Insider Report for Outset Medical, Inc. (OM)

Role
Chief People Officer
Signature
By: John L. Brottem For: Stacey L. Porter
Stock symbol
OM
Transactions as of
Oct 15, 2021
Transactions value $
$0
Form type
3
Date filed
10/21/2021, 05:03 PM
Next filing
Oct 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OM Common Stock 11.8K Oct 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OM Non-Qualified Stock Option (right to buy) Oct 15, 2021 Common Stock 31.1K $4.11 Direct F1
holding OM Non-Qualified Stock Option (right to buy) Oct 15, 2021 Common Stock 7.9K $6.25 Direct F2
holding OM Non-Qualified Stock Option (right to buy) Oct 15, 2021 Common Stock 1.9K $8.62 Direct F2
holding OM Non-Qualified Stock Option (right to buy) Oct 15, 2021 Common Stock 10.3K $46.94 Direct F3
holding OM Performance Options (right to buy) Oct 15, 2021 Common Stock 20.8K $4.11 Direct F4
holding OM Performance Options (right to buy) Oct 15, 2021 Common Stock 5.27K $6.25 Direct F4
holding OM Performance Options (right to buy) Oct 15, 2021 Common Stock 1.27K $8.62 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in 48 equal monthly installments beginning on December 12, 2018, subject to the reporting person's continued employment through the applicable vesting date.
F2 This option vests in 48 equal monthly installments, subject to the reporting person's continuous service through the applicable vesting date.
F3 This option vests 25% on March 8, 2022 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F4 All shares subject to this grant fully vested on March 15, 2021, after meeting performance criteria.